BR100 Decreased By (-0.61%)
BR30 Decreased By (-0.42%)
KSE100 Decreased By (-0.5%)
KSE30 Decreased By (-0.63%)
AGHA 7.66 Decreased By ▼ -0.15 (-1.92%)
BECO 5.17 Decreased By ▼ -0.04 (-0.77%)
BML 57.58 Increased By ▲ 0.08 (0.14%)
BOP 34.04 Increased By ▲ 0.01 (0.03%)
CNERGY 10.11 Increased By ▲ 0.15 (1.51%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 54.00 Decreased By ▼ -0.70 (-1.28%)
FFL 16.56 Decreased By ▼ -0.13 (-0.78%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 7.25 Decreased By ▼ -0.15 (-2.03%)
KOSM 5.77 No Change ▼ 0.00 (0%)
LOTCHEM 29.33 Increased By ▲ 0.01 (0.03%)
MLCF 92.98 Decreased By ▼ -1.38 (-1.46%)
NBP 202.05 Decreased By ▼ -1.00 (-0.49%)
NCPL 57.08 Increased By ▲ 0.08 (0.14%)
NPL 67.40 Decreased By ▼ -0.30 (-0.44%)
OGDC 315.34 Decreased By ▼ -0.50 (-0.16%)
PACE 10.65 Increased By ▲ 0.01 (0.09%)
PAEL 42.65 Decreased By ▼ -0.55 (-1.27%)
PIBTL 16.58 Decreased By ▼ -0.16 (-0.96%)
PPL 218.50 Decreased By ▼ -1.28 (-0.58%)
PRL 51.68 Increased By ▲ 2.49 (5.06%)
PTC 70.45 Decreased By ▼ -0.08 (-0.11%)
SSGC 27.40 Decreased By ▼ -0.85 (-3.01%)
TBL 9.79 Decreased By ▼ -0.07 (-0.71%)
TELE 8.70 Decreased By ▼ -0.09 (-1.02%)
TPL 18.35 Increased By ▲ 0.11 (0.6%)
TPLP 13.50 Increased By ▲ 0.23 (1.73%)
TREET 22.56 Decreased By ▼ -0.16 (-0.7%)
TRG 59.87 Decreased By ▼ -0.27 (-0.45%)
Markets

CBOT soybeans to test resistance at $12.69-1/4

8 The contract is riding on a wave 3 that is travelling towards the range of $12.69-1/4 to $12.77-3/4, formed by its 338.2% and 361.8% projection levels.
Published Updated
By

SINGAPORE: The CBOT soybean January contract is expected to test a resistance at $12.69-1/4 per bushel, with a good chance of breaking above this level and rising towards $12.77-3/4.

The contract is riding on a wave 3 that is travelling towards the range of $12.69-1/4 to $12.77-3/4, formed by its 338.2% and 361.8% projection levels.

Support is at $12.61, a break below which may cause a fall into $12.51-$12.56 range.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.